 |
Articles: Drug/Product Approvals |
Prior Articles
FDA Accepts for Filing Mylans ANDA for Generic CopaxoneÂ
Mylan, 09/15/09
FDA Classifies Voluntary Notification Related to SC Catheters and IsoMed Pump Incompatibility as Class I Recall
Medtronic, 09/15/09
Free full text
Abbott Receives European Approval for Once-Daily Dosing of Kaletra Tablet
Abbott, 09/15/09 Abbott Announces Approval in China for Next-Generation XIENCE V Drug Eluting Stent
Abbott, 09/15/09 Financing of U.S. Biomedical Research and New Drug Approvals across Therapeutic Areas
PLoS ONE - Cardiovascular Disorders, 09/14/09 Par Pharmaceutical Receives Final Approval To Market Generic Starlix
Par Pharmaceutical, 09/11/09 CV Therapeutics and Astellas Announce FDA Approval for Lexiscan (regadenoson) Injection
Astellas, 09/11/09
Free full text
CryoLife Announces First Clinical Use of BioFoam
Cryolife, 09/11/09
Free full text
FDA approves astellas' vaprisol (conivaptan hydrochloride injection) premixed in 5% dextrose for the treatment of hyponatremia
Astellas, 09/11/09
Free full text
Additional clinical trial to be conducted for kynapid under fda special protocol agreement
Astellas, 09/11/09
Free full text
Breaking the Rapid Microbiological Method Financial Barrier: A Case Study in Return on Investment and Economic Justification
BioPharm, 09/11/09
Free full text
Astellas receives FDA approval for use of progr (tacrolimus) in conjunction with mycophenolate mofetil (mmf) in kidney transplant recipients
Astellas, 09/11/09
Free full text
FDA Advisory Committee makes favorable recommendation for Cervarix, GlaxoSmithKlines candidate cervical cancer vaccine
GlaxoSmithKline, 09/10/09
Free full text
Inspire Committed to Helping Healthcare Providers and Patients During Erythromycin Ophthalmic Ointment Shortage
Inspire, 09/10/09
Free full text
FDA Advisory Committee Recommends Approval for Use of GARDASIL in Boys and Men
Merck & Co., 09/10/09
Free full text
Synthon announces European approvals for generic Rivastigmine
Synthon, 09/10/09
Free full text
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09
Free full text
Electronic Safety Reporting May Soon Be Mandatory, says FDA
Pharmaceutical Technology, 09/09/09
Free full text
Novel evidence-based systemic lupus erythematosus (sle) responder index described in peer reviewed publication as potentially significant advance in lupus drug development
Human Genome Sciences, 09/08/09
Free full text
Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOSÂ for the Treatment of Type 2 Diabetes
Takeda Pharmaceuticals North America, 09/08/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
